封面
市場調查報告書
商品編碼
1736415

全球醫療射出成型市場-按材料、系統、產品、地區和預測的市場規模

Global Medical Injection Molding Market Size By Material, By Systems, By Product, By Geographic Scope and Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

醫療射出成型市場規模及預測

2024 年醫療射出成型市場規模價值 230.4 億美元,預計到 2032 年將達到 341.2 億美元,2026 年至 2032 年的複合年成長率為 5.55%。

  • 醫用射出成型是一種專業的製造方法,能夠生產出高精度、一致性高、品質優的醫用塑膠零件。此方法將熔融的塑膠零件注入模腔,冷卻並固化成所需形狀。醫用射出成型成型對於製造各種醫療設備中使用的先進複雜部件至關重要,包括注射器、植入、手術器材和診斷工具。
  • 該系統廣泛應用於各種醫療設備和零件的製造,確保高精度、高可靠性和一致性——這些都是醫療保健產業的關鍵要素。最常見的應用之一是生產手術器械,例如鉗子、牽開器和夾鉗。這些器材設計精良,必須符合高品質標準,才能在醫療過程中順利安全地發揮作用。
  • 對極其精密可靠的醫療部件的需求正在推動醫療射出成型的未來發展。隨著醫療設備和器械的日益先進,製造流程的精確度至關重要。未來的射出成型技術將利用微成型和奈米技術等尖端技術,生產公差極小、結構複雜的零件。

全球醫療射出成型市場動態

影響全球醫療射出成型市場的關鍵市場動態是:

關鍵市場促進因素

  • 醫療技術和材料的進步:醫療射出成型市場的主要驅動力之一是醫療技術和材料的進步。醫療產業需要能夠利用射出成型技術高效生產的高精度、高可靠性零件。
  • 射出成型技術進步:射出成型技術的發展是醫療射出成型產業的另一個主要驅動力。微射出成型、多材料成型以及自動化技術進步等創新大大改進了射出成型操作。微射出成型能夠生產極微小且精密的零件,而這些零件在微創手術和植入式醫療設備中的需求日益成長。
  • 嚴格的監管標準和品管:醫療設備對安全性、品質和性能有嚴格的要求,醫療產業也受到廣泛的監管。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構對醫療設備製造商制定了嚴格的規定。醫療射出成型作業必須遵守這些準則,以確保生產的零件不含雜質和缺陷。

主要挑戰

  • 嚴格的法規合規性:醫療射出成型最具挑戰性的方面之一是滿足嚴格的監管標準。醫療產業受到嚴格監管,美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等機構對醫療設備和零件的製造實施了嚴格的標準。
  • 材料選擇與相容性:選擇合適的醫用射出成型材料至關重要,但由於醫療應用的獨特需求,選擇合適的材料也極具挑戰性。所用材料必須具有生物相容性、耐久性,並且能夠耐受高壓高壓釜、伽馬射線輻照和環氧乙烷處理等滅菌技術。此外,材料還必須具備理想的機械性能,包括柔韌性、強度和耐化學性。
  • 精度與品管:醫療射出成型需要高精度和嚴格的品管,才能生產出符合嚴格標準的零件。醫療設備具有複雜的幾何形狀和嚴格的公差,必須一致地滿足這些要求,才能確保其功能性和安全性。維持這種完美品質需要創新的成型技術、先進的設備以及嚴格的檢驗和測試通訊協定。

主要趨勢:

  • 採用先進材料:醫療射出成型成型的一個關鍵發展是先進材料的使用日益增多。聚丙烯和聚乙烯正在被聚醚醚酮 (PEEK)、聚碳酸酯 (PC) 和熱可塑性橡膠(TPE) 等高性能聚合物所補充,在某些情況下甚至被取代。
  • 精密和微成型能力:精密和微成型能力在醫療射出成型產業中日益重要。醫療器材越來越小,需要複雜而精密的零件。微成型能夠生產公差高、形狀複雜的微型零件,滿足微創手術器械、藥物輸送系統和微流體設備等應用的需求。
  • 自動化和智慧生產:自動化和智慧生產正在徹底改變醫療射出成型產業。機器人、人工智慧 (AI) 和物聯網 (IoT) 在製造過程中的應用提高了效率、品質和可追溯性。自動化系統可以更快、更準確地執行重複性任務,從而降低人為錯誤的風險並提高生產力。

目錄

第1章:全球醫療射出成型市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章:已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球醫療射出成型市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球醫療射出成型市場(按材料)

  • 概述
  • 塑膠
  • 金屬
  • 其他

6. 全球醫療射出成型市場(按系統)

  • 概述
  • 熱流道
  • 冷流道

第7章全球醫療射出成型市場(按產品)

  • 概述
  • 醫療設備組件
  • 耗材
  • 病人輔助器具
  • 整形外科設備
  • 牙科產品
  • 其他

8. 全球醫療射出成型市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第9章全球醫療射出成型市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第10章 公司簡介

  • C&J INDUSTRIES
  • All-Plastics
  • Biomerics
  • HTI Plastics
  • The Rodon Group
  • EVCO Plastics
  • Majors Plastics, Inc
  • Proto Labs, Inc
  • Tessy Plastics
  • Currier Plastics, Inc.

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 36128

Medical Injection Molding Market Size And Forecast

Medical Injection Molding Market size was valued at USD 23.04 Billion in 2024 and is projected to reach USD 34.12 Billion by 2032, growing at a CAGR of 5.55% during the forecast period 2026-2032.

  • Medical injection molding is a specialized manufacturing method that produces medical-grade plastic components with exceptional precision, consistency, and quality. This method includes injecting molten plastic components into a mold cavity, where they cool and solidify to the desired shape. The medical injection molding method is very important for making sophisticated and intricate components used in a variety of medical devices, including syringes, implants, surgical instruments, and diagnostic tools.
  • This system is widely utilized in the manufacturing of a variety of medical devices and components ensuring high precision, dependability, and consistency all of which are vital in the healthcare industry. One of the most common applications is the manufacture of surgical equipment like forceps, retractors, and clamps. These instruments must be intricately designed and meet high-quality criteria to perform successfully and safely during medical procedures.
  • The requirement for extremely precise and reliable medical components is propelling the future of medical injection molding forward. As medical devices and equipment become more advanced, precision in manufacturing processes is critical. Future injection molding technologies will use cutting-edge advancements like micro molding and nanotechnology to create exceedingly small and complicated components with tight tolerances.

Global Medical Injection Molding Market Dynamics

The key market dynamics that are shaping the global medical injection molding market include:

Key Market Drivers:

  • Advances in Medical Technology and Materials: One of the key drivers of the medical injection molding market is the ongoing progress of medical technology and materials. The medical business requires extremely precise and reliable components that may be efficiently manufactured utilizing injection molding techniques.
  • Technological Advancements in Injection Molding: Technological developments in injection molding are another significant driver of the medical injection molding industry. Innovations such as micro-injection molding, multi-material molding, and increased automation have considerably improved injection molding operations. Micro-injection molding enables the manufacture of extremely small and delicate components which are increasingly required for minimally invasive surgical and implanted medical devices.
  • Stringent Regulatory Standards and Quality Control: The medical business is extensively regulated, with strict safety, quality, and performance requirements for medical equipment. Regulatory authorities such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require medical device makers to follow strict rules. Medical injection molding operations must adhere to these guidelines guaranteeing that the components produced are free of impurities and flaws.

Key Challenges:

  • Severe Regulatory Compliance: One of the most difficult aspects of medical injection molding is meeting severe regulatory criteria. The medical business is heavily regulated with authorities like the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe imposing stringent standards on the manufacture of medical devices and components.
  • Material Selection and Compatibility: Choosing the right materials for medical injection molding is vital but difficult due to the specific needs of medical applications. The materials utilized must be biocompatible, long-lasting, and resistant to sterilization techniques like autoclaving, gamma irradiation, or ethylene oxide treatment. Additionally, they must have the desired mechanical qualities, such as flexibility, strength, and chemical resistance.
  • Precision and Quality Control: To make components that satisfy rigorous standards, medical injection molding demands a high level of precision and stringent quality control. Medical equipment can have complex geometries and strict tolerances which must be consistently satisfied to ensure appropriate function and safety. Maintaining this degree of perfection requires innovative molding techniques, cutting-edge machinery, and stringent inspection and testing protocols.

Key Trends:

  • Adoption of Sophisticated Materials: One important development in medical injection molding is the increased usage of sophisticated materials. Polypropylene and polyethylene are being supplemented and in some cases replaced, by high-performance polymers such as polyetheretherketone (PEEK), polycarbonate (PC), and thermoplastic elastomers (TPE).
  • Precision and Micro-Molding Capabilities: Precision and micro-shaping capabilities are becoming increasingly important in the medical injection molding business. Medical gadgets are becoming progressively shrunk necessitating intricate and accurate components. Micro-molding produces extremely small parts with high tolerances and complicated geometries which are required for applications such as minimally invasive surgical instruments, drug delivery systems, and microfluidic devices.
  • Automation and Smart Manufacturing: Automation and smart production are revolutionizing the medical injection molding business. The use of robotics, artificial intelligence (AI), and the Internet of Things (IoT) in manufacturing processes improves efficiency, quality, and traceability. Automated systems can do repetitive activities more quickly and accurately lowering the risk of human error and increasing production productivity.

Global Medical Injection Molding Market Regional Analysis

Here is a more detailed regional analysis of the global medical injection molding market:

Asia Pacific:

  • The Asia-Pacific region is emerging as a prominent force in the medical injection molding market owing to a mix of variables such as a large and aging population, rising chronic disease rates, and rapid economic expansion. The United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) projects that the region's population will reach 4.6 billion by 2050 with the senior population (aged 65 and up) likely to double from 395 million in 2020 to 783 million by 2050. This demographic transition is especially significant in countries like Japan where the National Institute of Population and Social Security Research forecasts that 28.4% of the population will be 65 or older in 2020 with that percentage predicted to climb to 35.3% by 2040.
  • For example, the International Diabetes Federation (IDF) predicted that in 2019, 163 million persons in the Western Pacific region had diabetes with the figure expected to climb to 212 million in 2045. These demographic and health trends are driving the demand for injection-molded medical devices and components such as insulin delivery systems, diagnostic equipment, and other medical implants. Furthermore, the rapid expansion of the healthcare sector in Asia-Pacific countries is driving the medical injection molding market forward. China for example has made significant investments in healthcare infrastructure and technology. According to the National Health Commission of China, healthcare spending in the country will total 6.52 trillion yuan (about USD 1 trillion) in 2020 up 10.2% over the previous year.

North America:

  • The medical injection molding market in North America is rapidly expanding owing to a combination of reasons such as an aging population, an increase in the frequency of chronic diseases, and technological advances in healthcare. According to the United States Census Bureau, the number of Americans aged 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060 with their share of the total population rising from 16% to 23%. This demographic transition has a substantial impact on the demand for medical devices and injection-molded components. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 persons in the United States have at least one chronic disease with 4 in 10 having two or more.
  • Chronic diseases such as heart disease, cancer, and diabetes are America's major causes of mortality and disability, necessitating the development of innovative medical technologies and therapies. The medical injection molding market in North America is being fueled by increased investments in healthcare infrastructure and research and development. The National Institutes of Health (NIH) budget for fiscal year 2021 was USD 42.9 Billion representing a significant increase over previous years and demonstrating a strong commitment to medical research and innovation.

Global Medical Injection Molding Market: Segmentation Analysis

The Global Medical Injection Molding Market is segmented based on Material, Systems, Product, and Geography.

Medical Injection Molding Market, By Material

  • Plastics
  • Metals
  • Others

Based on the Material, the Global Medical Injection Molding Market is bifurcated into Plastics, Metals, and Others. Plastics dominate the global medical injection molding market due to their versatility, cost-effectiveness, and excellent properties for medical applications. Plastics such as polypropylene, polyethylene, and polyetheretherketone (PEEK) offer high biocompatibility, chemical resistance, and mechanical strength making them ideal for producing a wide range of medical components like syringes, implants, and diagnostic devices. Additionally, plastics can be easily sterilized and molded into complex shapes with precise tolerances which is essential for the medical industry.

Medical Injection Molding Market, By Systems

  • Hot Runner
  • Cold Runner

Based on Systems, the Global Medical Injection Molding Market is bifurcated into Hot Runner and Cold Runner. The hot runner system is dominant in the global medical injection molding market. This dominance is due to its numerous advantages over the cold runner system, particularly in producing high-precision medical components. Hot runner systems allow for better control of the molding process resulting in higher-quality parts with fewer defects. They eliminate the need for runners reducing material waste and lowering production costs. Additionally, hot runner systems enable faster cycle times and increased production efficiency essential for high-volume manufacturing.

Medical Injection Molding Market, By Product

  • Medical Equipment Components
  • Consumables
  • Patient Aids
  • Orthopedics Instruments
  • Dental Products
  • Others

Based on the Product, the Global Medical Injection Molding Market is bifurcated into Medical Equipment Components, Consumables, Patient Aids, Orthopedics Instruments, Dental Products, and Others. The dominant segment in the medical injection molding market is medical equipment components. This dominance is driven by the high demand for precision-engineered parts used in a wide range of medical devices such as diagnostic equipment, surgical instruments, and drug delivery systems. The need for components that meet strict regulatory standards for safety and biocompatibility is critical in the healthcare sector. Advances in injection molding technology allow for the production of complex, high-quality parts with tight tolerances which are essential for the reliable performance of medical equipment.

Medical Injection Molding Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Geography, the Global Medical Injection Molding Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global medical injection molding market. This dominance is attributed to several factors including the region's robust healthcare infrastructure, high demand for advanced medical devices, and stringent regulatory standards favoring quality and innovation. North American countries particularly the United States are home to a significant number of medical device manufacturers and research institutions driving technological advancements in the field of medical injection molding. Moreover, the presence of a large patient population coupled with substantial healthcare expenditures fuels continuous demand for high-quality medical devices and components. The region's strong focus on healthcare innovation coupled with strategic investments in R&D and manufacturing capabilities, further solidifies North America's position as a leader in the global medical injection molding market.

Key Players

The "Global Medical Injection Molding Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are C&J INDUSTRIES, All-Plastics, Biomerics, HTI Plastics, The Rodon Group, EVCO Plastics, Majors Plastics, Inc., Proto Labs, Inc., Tessy Plastics, Currier Plastics, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Medical Injection Molding Market Key Developments

  • In November 2023, ARBURG, a major participant in the medical injection molding sector, expanded its global reach by establishing a new subsidiary in Ho Chi Minh City, Vietnam. This strategic decision intends to make ARBURG's goods and services more accessible to clients in Vietnam, thereby enhancing the company's position in the region.
  • In September 2023, Milacron, a major leader in the worldwide plastics technology and processing business, delivered the injection molding machine to its long-term customer, Holiday City, Ohio-based 20/20 Custom Molded Plastics, LLC.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL INJECTION MOLDING MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL MEDICAL INJECTION MOLDING MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY MATERIAL

  • 5.1 Overview
  • 5.2 Plastics
  • 5.3 Metals
  • 5.4 Others

6 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY SYSTEMS

  • 6.1 Overview
  • 6.2 Hot Runner
  • 6.3 Cold Runner

7 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY PRODUCT

  • 7.1 Overview
  • 7.2 Medical Equipment Components
  • 7.3 Consumables
  • 7.4 Patient Aids
  • 7.5 Orthopedics Instruments
  • 7.6 Dental Products
  • 7.7 Others

8 GLOBAL MEDICAL INJECTION MOLDING MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL MEDICAL INJECTION MOLDING MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 C&J INDUSTRIES
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 All-Plastics
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Biomerics
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 HTI Plastics
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 The Rodon Group
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 EVCO Plastics
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Majors Plastics, Inc
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Proto Labs, Inc
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Tessy Plastics
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Currier Plastics, Inc.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research